Viewing Study NCT01858558


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2026-05-20 @ 5:32 PM
Study NCT ID: NCT01858558
Status: COMPLETED
Last Update Posted: 2020-06-29
First Post: 2013-05-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords: